메뉴 건너뛰기




Volumn 160, Issue 32, 1998, Pages 4617-4621

New prognostic markers in colorectal cancer;Nye prognostiske markører ved kolorektal cancer

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

EID: 0032479610     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (2)

References (27)
  • 1
    • 0027453110 scopus 로고
    • Preoperative evaluation and postoperative surveillance for patients with colorectal carcinoma
    • Vignati PV, Roberts PL. Preoperative evaluation and postoperative surveillance for patients with colorectal carcinoma. Surg Clin North Am 1993; 73: 67-84.
    • (1993) Surg Clin North Am , vol.73 , pp. 67-84
    • Vignati, P.V.1    Roberts, P.L.2
  • 2
    • 0031575475 scopus 로고    scopus 로고
    • Kolorektal cancer
    • Kronborg O. Kolorektal cancer. Ugeskr Læger 1997; 159:1064-5.
    • (1997) Ugeskr Læger , vol.159 , pp. 1064-1065
    • Kronborg, O.1
  • 3
    • 0030926036 scopus 로고    scopus 로고
    • Multimodal approach to control postoperative pathophysiology and rehabilitation
    • Kehlet H. Multimodal approach to control postoperative pathophysiology and rehabilitation. Br J Anaesth 1997; 78: 606-17.
    • (1997) Br J Anaesth , vol.78 , pp. 606-617
    • Kehlet, H.1
  • 4
    • 0029039734 scopus 로고
    • Detrimental effects of perioperative blood transfusion
    • Nielsen HJ. Detrimental effects of perioperative blood transfusion. Br J Surg 1995; 82: 582-7.
    • (1995) Br J Surg , vol.82 , pp. 582-587
    • Nielsen, H.J.1
  • 5
    • 0029382698 scopus 로고
    • Total mesorectal excision is optimal surgery for rectal cancer a Scandinavian consensus
    • Heald RJ. Total mesorectal excision is optimal surgery for rectal cancer a Scandinavian consensus. Br J Surg 1995; 82: 1297-9.
    • (1995) Br J Surg , vol.82 , pp. 1297-1299
    • Heald, R.J.1
  • 7
    • 0028224082 scopus 로고
    • Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes C colorectal cancer
    • Rietmüller G, Gädicke ES, Schlimok G, Schmiegel W, Raab R, Hȯffken K et al. Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes C colorectal cancer. Lancet 1994; 343: 1177-83.
    • (1994) Lancet , vol.343 , pp. 1177-1183
    • Rietmüller, G.1    Gädicke, E.S.2    Schlimok, G.3    Schmiegel, W.4    Raab, R.5    Hoffken, K.6
  • 8
    • 0028086491 scopus 로고
    • Cancer vaccines
    • Dalgleish DG. Cancer vaccines. Eur J Cancer 1994; 30A, 1029-35.
    • (1994) Eur J Cancer , vol.30 A , pp. 1029-1035
    • Dalgleish, D.G.1
  • 11
    • 0000833880 scopus 로고    scopus 로고
    • Fighting cancer by attacking its blood supply
    • Folkman J. Fighting cancer by attacking its blood supply Sci Am 1996; 324: 116-9.
    • (1996) Sci Am , vol.324 , pp. 116-119
    • Folkman, J.1
  • 13
    • 0027994264 scopus 로고
    • The urokinase receptor. Protein structure and role in plasminogen activation and cancer invasion
    • Danø K, Behrent N, Brünner N, Ellis V, Pioug M, Pyke C. The urokinase receptor. Protein structure and role in plasminogen activation and cancer invasion. Fibrinolysis 1994; 8 (suppl 1): 189-203.
    • (1994) Fibrinolysis , vol.8 , Issue.1 SUPPL. , pp. 189-203
    • Danø, K.1    Behrent, N.2    Brünner, N.3    Ellis, V.4    Pioug, M.5    Pyke, C.6
  • 14
    • 0029086080 scopus 로고
    • Prognostic values of plasminogen activators and their inhibitors in colorectal cancer
    • Verspaget HW, Sier CFM, Ganesh S, Griffioen G, Lamers CB. Prognostic values of plasminogen activators and their inhibitors in colorectal cancer. Eur J Cancer 1995, 31A. 1105-9.
    • (1995) Eur J Cancer , vol.31 A , pp. 1105-1109
    • Verspaget, H.W.1    Sier, C.F.M.2    Ganesh, S.3    Griffioen, G.4    Lamers, C.B.5
  • 15
    • 2542452009 scopus 로고    scopus 로고
    • Urokinase plasminogen activator receptor in plasma is an independent prognostic variable in patients with colorectal cancer
    • Beveridge MJ, Assenmacher KC, Arnold PR, Baker LB, Vitah RM, eds. San Diego, USA
    • Stephens RW, Nielsen HJ, Thorlacius-Ussing O, Christensen IJ, Dane K, Brunner N. Urokinase plasminogen activator receptor in plasma is an independent prognostic variable in patients with colorectal cancer. I: Beveridge MJ, Assenmacher KC, Arnold PR, Baker LB, Vitah RM, eds. Proc AACR Annual Meeting, San Diego, USA, 1997; 38 436
    • (1997) Proc AACR Annual Meeting , vol.38 , pp. 436
    • Stephens, R.W.1    Nielsen, H.J.2    Thorlacius-Ussing, O.3    Christensen, I.J.4    Dane, K.5    Brunner, N.6
  • 17
    • 0017875251 scopus 로고
    • Colonic carcinoma. A quantitative assessment of leukocyte infiltration at the periphery of colonic tumours related to prognosis
    • Watt AG, House AK. Colonic carcinoma. A quantitative assessment of leukocyte infiltration at the periphery of colonic tumours related to prognosis. Cancer 1978; 41: 279-86.
    • (1978) Cancer , vol.41 , pp. 279-286
    • Watt, A.G.1    House, A.K.2
  • 18
    • 0029826974 scopus 로고    scopus 로고
    • Time-dependent spontaneous release of leukocyte and platelet-derived bioactive substances from stored human blood
    • Nielsen HJ, Reimert CM, Pedersen AN, Brunner N, Edvardsen L, Dybkjær E et al Time-dependent spontaneous release of leukocyte and platelet-derived bioactive substances from stored human blood. Transfusion 1996; 36: 960-65.
    • (1996) Transfusion , vol.36 , pp. 960-965
    • Nielsen, H.J.1    Reimert, C.M.2    Pedersen, A.N.3    Brunner, N.4    Edvardsen, L.5    Dybkjær, E.6
  • 21
    • 0030054914 scopus 로고    scopus 로고
    • Regulation of VEGF/VPF expression in tumor cells: Consequences for tumor growth and metastasis
    • Claffey KP, Robinson GS. Regulation of VEGF/VPF expression in tumor cells: consequences for tumor growth and metastasis. Cancer Metastasis Rev 1996; 15: 165-76.
    • (1996) Cancer Metastasis Rev , vol.15 , pp. 165-176
    • Claffey, K.P.1    Robinson, G.S.2
  • 22
    • 0029149810 scopus 로고
    • Tumour vasculature - A potential therapeutic target
    • Baillie CT, Winslet MC, Bradley NJ. Tumour vasculature - a potential therapeutic target. Br J Cancer 1995; 72: 257-67.
    • (1995) Br J Cancer , vol.72 , pp. 257-267
    • Baillie, C.T.1    Winslet, M.C.2    Bradley, N.J.3
  • 24
    • 0029944122 scopus 로고    scopus 로고
    • Angiostatin induces and sustains dormancy of human primary tumors in mice
    • O'Reilley MS, Holmgren L, Chen C, Folkman J. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nature Med 1996, 2: 689-92.
    • (1996) Nature Med , vol.2 , pp. 689-692
    • O'Reilley, M.S.1    Holmgren, L.2    Chen, C.3    Folkman, J.4
  • 25
    • 0026806148 scopus 로고
    • Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients
    • Undemann F, Schlimok G, Dirschedl P, Witte J, Riethmüller G. Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet 1992; 340: 685-9.
    • (1992) Lancet , vol.340 , pp. 685-689
    • Undemann, F.1    Schlimok, G.2    Dirschedl, P.3    Witte, J.4    Riethmüller, G.5
  • 27
    • 0028885643 scopus 로고
    • Individual development and uPA-receptor expression on disseminated tumour cells in bone marrow: A reference to early systemic disease in solid cancer
    • Heiss MM, Janacke A, Schlimok S, Gruetzner KU, Funke I, Babic R et al. Individual development and uPA-receptor expression on disseminated tumour cells in bone marrow: a reference to early systemic disease in solid cancer. Nature Med 1995; 1: 1035-41
    • (1995) Nature Med , vol.1 , pp. 1035-1041
    • Heiss, M.M.1    Janacke, A.2    Schlimok, S.3    Gruetzner, K.U.4    Funke, I.5    Babic, R.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.